Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-041330

President and CEO sold 5,498 shares at $25.65 ($141,005)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peetz Christopher President and CEO 2023-07-03 Sale −5,498 $25.65 $141,005 115,334 D
Open-market sales · 5,498 sh · avg $25.65 · $141,005
Loading xslF345X04/doc4.xml…